Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 426 to 450
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
PublicationsOutcomes of the public consultation on Appendix M of the Poisons Standard are now available
-
-
Meeting statementsCommunique from the third meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Publications
-
Scheduling decisions (final)Final decision on the scheduling of alkyl nitrites - a matter which was most recently referred to the March 2019 Joint Advisory Committees on Medicines and Chemicals Scheduling (Joint ACMS-ACCS#21).
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 4 July 2019
-
TGA laboratory testing reportsTGA Laboratories has released a report detailing testing of alkyl nitrite products
-
Scheduling decisions (final)Delegate-only scheduling final decisions are now available
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in November 2018
-
Scheduling decisions (final)Final decisions and reasons for NCEs and medicines and chemicals referred to the November 2018 scheduling meetings (ACMS #25, ACCS #23 and Joint ACMS-ACCS #20).
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 28 March 2019
-
Meeting statementsCommunique from the second meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
PublicationsThe Public Statement for the Generic Medicines Working Group face-to-face meeting in Canberra, October 2018
-
PublicationsThe Action Plan will further improve Australia’s medical device regulatory system and place patient safety first
-
PublicationsThe 2018 Half Yearly Performance Snapshot is now available
-
PublicationsPublic statement for the Generic Medicines Working Group face-to-face meeting in Switzerland, May 2018
-
PublicationsStatistics from inspections conducted from 1 September 2017 to 31 December 2018
-
PublicationsCommunique summarising outcomes of the alkyl nitrites public meetings in Sydney and Melbourne
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
TGA laboratory testing reportsThe TGA has tested a range of human insulin products and all met the applicable quality standards
-
Publications
-
Meeting statementsACM 12 meeting statement has been published